These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8981454)

  • 1. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
    Keck BJ; Lakoski JM
    Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
    Keck BJ; Lakoski JM
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
    Vinod KY; Subhash MN; Srinivas BN
    Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
    Keck BJ; Lakoski JM
    Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
    Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
    Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
    Koek W; Assié MB; Zernig G; France CP
    Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH; Nelson DL
    Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
    Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
    Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ.
    Raghupathi RK; Brousseau DA; McGonigle P
    Brain Res Mol Brain Res; 1996 Jun; 38(2):233-42. PubMed ID: 8793111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Keck J; Lakoski JM
    Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
    Pinto W; Battaglia G
    Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
    Raghupathi RK; Artymyshyn R; McGonigle P
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Ni YG; Camacho N; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299.
    Stenfors C; Werner T; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):500-7. PubMed ID: 9650801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists.
    Cox RF; Meller E; Waszczak BL
    Synapse; 1993 Aug; 14(4):297-304. PubMed ID: 8248853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.